Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 772 | 772 | 2,902 | 303 | 303 |
| Gross Profit | 772 | 772 | 2,902 | 303 | 303 |
| Operating Expenses | 7,603 | 3,952 | 5,813 | 7,640 | 8,141 |
| Operating Income | -6,831 | -3,180 | -2,911 | -7,336 | -7,838 |
| Interest Expense | 921 | 718 | 2,147 | 1,746 | 1,244 |
| Other Income | 212 | -1,174 | -818 | 3,751 | 1,036 |
| Pre-tax Income | -7,540 | -5,071 | -5,876 | -5,331 | -8,046 |
| Income Tax | N/A | -3,151 | 498 | N/A | N/A |
| Net Income Continuous | -7,540 | -1,921 | -6,373 | -5,331 | -8,046 |
| Net Income | $-7,540 | $-1,921 | $-6,373 | $-5,331 | $-8,046 |
| EPS Basic Total Ops | -53.20 | -113.60 | -46.40 | -35.20 | -54.40 |
| EPS Basic Continuous Ops | -46.88 | -12.29 | -37.86 | -34.90 | -54.26 |
| EPS Diluted Total Ops | -53.20 | -113.60 | -60.80 | -35.20 | -60.80 |
| EPS Diluted Continuous Ops | -46.88 | -12.29 | -37.82 | -34.90 | -54.09 |
| EBITDA(a) | $-6,100 | $-2,503 | $-2,241 | $-6,664 | $-7,158 |